NEW ATAI-Logo_Primary.png
atai Life Sciences gründet in Partnerschaft mit der University of Queensland InnarisBio mit dem Ziel, eine wirksamere nasale Verabreichungsmethode für atais Plattform therapeutischer Programme für mentale Gesundheit zu entwickeln
29 juil. 2021 09h19 HE | Atai Life Sciences
BERLIN und BRISBANE, Australien, July 29, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences(„atai“ oder das „Unternehmen“) (Nasdaq: ATAI), ein biopharmazeutisches Unternehmen im klinischen Stadium, das...
NEW ATAI-Logo_Primary.png
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
28 juil. 2021 09h12 HE | atai Life Sciences
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the...
NEW ATAI-Logo_Primary.png
atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
07 juil. 2021 19h47 HE | atai Life Sciences
BERLIN, Germany, July 07, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds...
NEW ATAI-Logo_Primary.png
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
17 juin 2021 23h21 HE | atai Life Sciences
BERLIN, June 17, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
NEW ATAI-Logo_Primary.png
atai Life Sciences Announces Launch of Initial Public Offering
11 juin 2021 07h59 HE | atai Life Sciences
BERLIN, June 11, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the...